🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1 study to assess the effect of itraconazole, a strong inhibitor of...
Status
Completed
Location
Parexel Epcu
Start Date
2018-06-08
Trial ID
NCT03535662
Treatments Being Tested
Efficacy and safety of Drug combination therapy of Isotretinoin and some An...
Status
Unknown
Location
Kafr El-sheikh University
Start Date
2020-10-20
Trial ID
NCT04577378
The primary objective of this study is to evaluate the feasibility of itrac...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-08-17
Trial ID
NCT07283497
Treatments Being Tested
The purpose of this exploratory study is to assess the efficacy, safety and...
Status
Completed
Location
Site 201
Start Date
2016-07
Trial ID
NCT02828241
Treatments Being Tested
This is a Phase 1, open-label, two-period, fixed sequence drug-drug interac...
Status
Completed
Location
Dallas Clinical Research Unit
Start Date
2024-11-15
Trial ID
NCT06690138
Treatments Being Tested
Chronic graft-versus-host disease (cGVHD) affects 30 to 70% of Allogeneic H...
Status
Unknown
Location
Hospital Universitario Dr. José Eleuterio González
Start Date
2022-04-01
Trial ID
NCT05348096
Treatments Being Tested
The main purpose of this study is to learn more about the safety and side e...
Status
Terminated
Location
Covance
Start Date
2019-08-09
Trial ID
NCT04014361
Treatments Being Tested
OBJECTIVES: I. Evaluate the tolerance of patients with blastomycosis, histo...
Status
Completed
Location
Multiple Locations
Start Date
1985-03
Trial ID
NCT00004811
Treatments Being Tested
The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 ...
Status
Recruiting
Location
Research Site
Start Date
2026-07-30
Trial ID
NCT07685600
Treatments Being Tested
This study will be conducted in three parts (Part 1, Part 2 and Part 3). Pa...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-01-28
Trial ID
NCT02045849
Treatments Being Tested